Lantern Pharma Inc. ($LTRN)
Filing Information
| Accession Number | 0001493152-26-023082 |
|---|---|
| Form Type | 4 |
| Filing Date | May 14, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
97,088
Total Value
$100,000.64
P&L
+203.9% (+$203,884.80)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common stock, $0.001 par value | โ | May 12, 2026 | Purchase | 48,544 | $2.06 | $100,000.64 | 94,303 | Direct | โ | View Details | |
Director | Common stock purchase warrant (Right to Buy) | Derivative | May 12, 2026 | Purchase | 48,544 | $0.00 | $0.00 | 48,544 | Direct | โ | View Details |